Who
Gino Santini
Director
Company insider
Files Form 4 as: Director, Collegium Pharmaceutical; Director, COMPASS Pathways; Director, Intercept Pharmaceuticals; Director, Horizon Therapeutics Public Ltd Co; Director, Allena Pharmaceuticals; Director, Amag Pharmaceuticals; Director, Vitae Pharmaceuticals; Sr.VP, Corp. Strategy & BD, Eli Lilly and.
In numbers
- Trades disclosed
- 213
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $1.3M
- Companies
- 8
- Companies where not an officer
- 7
- First trade
- 5 Aug 2004
- Last trade
- 8 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 10 Jun 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code M | $143K8,700 at $16.49 | filing |
| 8 Jun 2026filed 10 Jun 2026 | COLL Collegium Pharmaceuticaloption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,700 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | COLL Collegium Pharmaceuticaloption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —8,700 at $0.00 | filing |
| 8 Jun 2026filed 10 Jun 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code M | $143K8,700 at $16.49 | filing |
| 27 May 2026filed 29 May 2026 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,158 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,158 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —8,741 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —8,741 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | COLL Collegium Pharmaceuticaloption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code M | $202K15,000 at $13.45 | filing |
| 15 Aug 2025filed 19 Aug 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $201K5,405 at $37.19 | filing |
| 12 Jun 2025filed 13 Jun 2025 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,000 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —9,791 at $0.00 | filing |
| 3 Sep 2024filed 4 Sep 2024 | CMPS COMPASS Pathwaysoption or derivative · Biotechnology | SEC FORM 4 Code A | —52,000 at $0.00 | filing |
| 16 May 2024filed 16 May 2024 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —7,693 at $0.00 | filing |
| 8 Nov 2023filed 13 Nov 2023 | Intercept Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —12,089 | filing |
| 8 Nov 2023filed 13 Nov 2023 | Intercept Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —12,790 | filing |
| 8 Nov 2023filed 13 Nov 2023 | Intercept Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —12,547 | filing |
| 8 Nov 2023filed 13 Nov 2023 | Intercept Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —3,500 | filing |
| 8 Nov 2023filed 13 Nov 2023 | Intercept Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —1,598 | filing |
News
Head to Head Survey: Collegium Pharmaceutical (NASDAQ:COLL) versus Journey Medical (NASDAQ:DERM)COLL · dailypolitical.com · 22 Oct 2026Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Has Consensus Price Target of $48.71COLL · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Gino Santini; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.